Evaluation of Kidney Function in Cirrhosis: Methods and Pitfalls.

Area of Science:

• Nephrology
• Hepatology
• Clinical Chemistry

Background:

• Renal dysfunction, including acute kidney injury (AKI) and chronic kidney disease (CKD), is prevalent in cirrhosis.
• It significantly impacts patient prognosis, management, and liver transplant eligibility.
• The pathophysiology involves hemodynamic changes, inflammation, and direct kidney injury.

Purpose of the Study:

• To review the causes of renal dysfunction in cirrhosis.
• To evaluate current methods for assessing kidney function in this population.
• To highlight the limitations of existing tools and the need for improved methods.

Main Methods:

• Literature review of studies on renal dysfunction in cirrhosis.
• Analysis of the performance and limitations of various kidney function assessment tools.
• Discussion of newer, cirrhosis-specific equations and their validation.

Main Results:

• Serum creatinine and estimated glomerular filtration rate (eGFR) are limited by factors like reduced creatinine production and hyperbilirubinemia, often overestimating true GFR.
• Alternative methods (cystatin C, urine clearance, exogenous markers) have potential but also limitations, especially in decompensated cirrhosis.
• Newer cirrhosis-specific eGFR equations show inconsistent accuracy.

Conclusions:

• Accurate kidney function assessment is critical for MELD score, transplant allocation, and clinical decisions in cirrhosis.
• Existing creatinine-based methods are flawed, and alternative approaches have limitations.
• There is an unmet need for validated, reliable kidney function tests for cirrhotic patients, though serum creatinine remains the practical standard for now.